Janet Yellen Named New Fed Chief

Jacob Harper  |

On Oct. 8 President Obama picked Janet Yellen to succeed Ben Bernanke as the Chairman of the Federal Reserve, in a move that was widely expected by analysts.

A former Harvard professor who has been serving as Vice Chair since 2010, Yellen is widely seen as ideologically similar to Bernanke, and is expected to continue Bernanke’s policies more or less in a similar fashion as her predecessor would have.

The most scrutinized decision Yellen will make in the near-term is whether or not to “taper” the open-ended $85 billion a month bond-buying program known as quantitative easing, or QE3. Despite persistent speculation to the contrary, Bernanke has so far declined to taper that program, citing the still-recovering American economy.

Concerning interest rates, Yellen was a key architect in keeping them low, and will most likely continue to keep them that way to prop up the banking the sector.

Yellen became the frontrunner for the position after Obama’s preferred choice, the hawkish Lawrence Summers, withdrew his name for consideration. Summers is far more conservative than Yellen, and was almost certain to taper or even outright terminate quantitative easing.  

Summers was expected to face stiff resistance from the liberal wing of the Democratic Party because of his more laissez-faire attitudes.

Conversely, Yellen enjoys widespread support with liberals, and also European and Asian financial leaders who suspect she might even be more dovish than Bernanke on government stimulus.  

Yellen will take over as chair of the Fed on Feb. 1. She will the first woman to head up the Fed in its history.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Companies

Symbol Name Price Change % Volume
CWFNF Canadian Wrld Fund Ltd n/a n/a n/a 0

Comments

Watchlist

Symbol Last Price Change % Change
AAPL

     
AMZN

     
HD

     
JPM

     
IBM

     
BA

     
WMT

     
DIS

     
XOM

     

Level Headed at World Crypto Con - Steve Beauregard

Bloq.com CRO Steve Beauregard joins Jack Brewer at World Crypto Con.

Emerging Growth

IMV Inc.

Immunovaccine Inc is clinical stage biopharmaceutical company. The Company develops products based on its proprietary vaccine enhancement platform in T cell activating therapies for cancer.